Cancer Treatment Reviews
Volume 31, Issue 6 , Pages 487-490 , October 2005

Adjuvant UFT therapy does not increase survival in people with resected stage 1 non-small cell lung cancer

References 

  1. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br Med J 1995;311:899–909.
  2. Wada H, Hitomi S, Takashi T West Japan Study Group for Lung Cancer Surgery. Adjuvant chemotherapy after complete resection in non-small cell lung cancer. J Clin Oncol. 1996;14:1048–1054
  3. Hamada C, Ohta M, Wada H, et al. Survival benefit of oral UFT for adjuvant chemotherapy after completely resected non-small cell lung cancer. Proc Am Soc Clin Oncol. 2004;22:A7002

☆ Sources of funding: Taiho pharmaceuticals Co., Ltd., Tokyo, Japan.

☆☆ For correspondence: Dr. H. Wada, Department of Thoracic Surgery,Kyoto University Hospital, Shogoin-kawara-cho 54, Sakyo-ku, Kyoto, 606-8507, Japan. Tel: +81 75 751 3835; fax: +81 75 751 4647. E-mail: wadah@kuhp.kyoto-u-ac.jp

☆☆☆ Abstract provided by Bazian Ltd., London.

PII: S0305-7372(05)00133-7

doi: 10.1016/j.ctrv.2005.07.002

Cancer Treatment Reviews
Volume 31, Issue 6 , Pages 487-490 , October 2005

Article Tools